Iradimed Corp (IRMD)
Sector: Healthcare
Industry: Surgical & Medical Instruments & Apparatus
Country: United States
Exchange: NASDAQ
Market cap: $1.05B
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
Latest financial period: June 30, 2026
Filed with the SEC: July 31, 2026
Estimated earnings date: November 2, 2026
Profit #208 of 1484 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROE/ROA | 85.5% | 87.2% | 87.4% | 86.1% |
Growth #807 of 1484 companies
Payout #227 of 1484 companies
Safety #44 of 1484 companies
Price #1133 of 1484 companies
